You balance hormones to clear acne by lowering androgen activity on the skin's oil glands — in practice that means a prescription anti-androgen (spironolactone), a combined oral contraceptive pill, or the topical androgen-blocker clascoterone. Androgens are hormones, including testosterone, that drive the oil production and gland growth behind inflamed breakouts; blocking their effect on the gland is the only "hormone balancing" with trial evidence behind it. What this does not mean is a diet, supplement, or detox that resets your hormones. The 2024 American Academy of Dermatology acne guideline puts the hormone-modulating options squarely in the prescription column, and the expected timeline is months, not weeks.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- The three hormone-targeting treatments that have evidence
- How well does spironolactone actually work?
- Why six months is the honest timeline
- Do you need a hormone blood test first?
- Choosing between the options
- The cost problem with the topical option
- Frequently Asked Questions
The three hormone-targeting treatments that have evidence
Oral spironolactone is a blood-pressure drug that also blocks androgen receptors. The AAD's 2024 acne guideline conditionally recommends it at moderate certainty of evidence, and states plainly that it should not be used during pregnancy. Combined oral contraceptive pills sit at the same strength.
The same guideline conditionally recommends them, also at moderate certainty — so the two systemic hormone options are peers, both ranked below isotretinoin, the only systemic acne drug the AAD recommends strongly. The third option is topical. WINLEVI (clascoterone) cream 1% is an androgen receptor inhibitor approved for acne in patients aged 12 and up, per its FDA-approved label: each gram holds 10 mg of clascoterone, applied as a thin layer of about 1 gram twice daily.
How well does spironolactone actually work?
The SAFA trial is the largest randomised test. It gave 201 women 50 mg of spironolactone daily to week 6, rising to as much as 100 mg daily through week 24, against placebo in 209 women — 410 participants in total, aged 18 and over, with moderate-to-severe persistent facial acne, published in the BMJ in May 2023. At week 12, investigators rated 31 of 201 women on spironolactone as treatment successes, versus 9 of 209 on placebo — an odds ratio of 5.18.
The quality-of-life gap widened over time: the adjusted Acne-QoL difference was 1.27 at 12 weeks and 3.45 at 24 weeks. Read those two numbers together. Most women in the trial were not clear at three months; the drug beat placebo clearly, but it is a meaningful improvement for a minority at that point, not a reliable clearance.
Why six months is the honest timeline
The 12-week result came with a real limitation. SAFA's week-12 Acne-QoL gain fell below the 2-point difference the trial had pre-set as clinically meaningful, and patient-reported improvement at that point was not statistically significant — 72% versus 68%, an odds ratio of 1.16, as the published trial report sets out. By 24 weeks the quality-of-life difference had grown past that threshold.
The practical reading: judge hormonal therapy at roughly six months, not at six weeks. That changes how you handle the early months. If you stop at week 8 because nothing has happened, you have not tested the treatment — you have only confirmed it is slow.
Do you need a hormone blood test first?
Usually not. The 2023 International Evidence-based PCOS Guideline states that acne without hirsutism — excess coarse hair growth in a male pattern — is a relatively weak predictor of biochemical hyperandrogenism in adults, and counts only *severe* acne toward hyperandrogenism in adolescents, because ordinary acne overlaps normal puberty. The guideline is also specific about when testing earns its keep: biochemical androgen testing is most valuable when clinical signs are minimal or absent.
Where the signs are visible, the signs are the information. It then directs clinicians to monitor acne, hirsutism and female-pattern hair loss during treatment to judge whether therapy is working or needs adjusting. In other words, the follow-up measure is your skin and hair, not a repeat lab panel.
Choosing between the options
A 2025 review of hormonal acne therapy notes that COC brands and doses show broadly similar acne efficacy. So the choice is not about finding the one magic pill — it rests on shared decision-making over contraceptive needs, other medical conditions, access and cost. Spironolactone is commonly paired with a COC specifically to prevent pregnancy.
- **Want contraception as well?** A COC covers both purposes at equal guideline strength.
- **Already on reliable contraception?** Spironolactone is the direct anti-androgen, with SAFA-grade trial data.
- **Prefer to avoid a systemic drug?** Clascoterone cream works at the receptor on the skin, and is labelled from age 12.
- **Pregnant or planning pregnancy?** The AAD guideline states spironolactone should not be used in pregnancy.
- **Cost is the deciding factor?** Ask about price before you commit to any of the three.
The cost problem with the topical option
Clascoterone is the one case where the evidence and the recommendation diverge. The AAD graded it only *conditional* despite high certainty of evidence, and its guideline summary names the reason: the drug's current cost as a barrier to equitable access. That is worth knowing before you ask for it.
The one topical anti-androgen on the market is held back by price, not by whether it works — so a prescription you cannot afford to refill twice daily is a treatment plan on paper only. Bring the cost question into the first conversation rather than the third. At 1 gram twice daily, the quantity used is fixed by the label, which makes the monthly spend predictable enough to compare directly against a generic pill before you start.
Frequently Asked Questions
Can diet or supplements balance my hormones enough to clear acne?
The guideline-backed hormone-targeting treatments for acne are all prescriptions: spironolactone, combined oral contraceptive pills, and clascoterone cream. Nothing in that evidence base supports a dietary or supplement route to the same effect.
What dose of spironolactone is used for acne?
In the SAFA trial, women took 50 mg daily to week 6, then up to 100 mg daily through week 24. Your own dose is a prescriber's decision, but that is the range the trial evidence covers.
Why is spironolactone usually prescribed alongside birth control?
A 2025 review of hormonal acne therapy notes the pairing exists to prevent pregnancy, since the AAD guideline states spironolactone should not be used during pregnancy.
Can teenagers use these treatments?
Clascoterone cream 1% is FDA-approved for acne in patients 12 years and older. The PCOS guideline also treats adolescent acne cautiously as a hormonal sign, counting only severe acne toward hyperandrogenism because breakouts are common in normal puberty.